XRF Scientific Limited (AU:XRF)
ASX:XRF
Want to see AU:XRF full AI Analyst Report?
Top Page
XRF Scientific Limited
(Sydney:XRF)
Select Model
Select Model
Rating:67Neutral
Price Target:
AU$2.00
▲(7.53% Upside)
Action:Reiterated
Date:12/11/25
XRF Scientific Limited's overall stock score reflects strong financial performance with efficient operations and a solid balance sheet. However, mixed technical indicators and moderate valuation suggest limited growth potential without new catalysts. The absence of earnings call insights and corporate events further limits the score.
Positive Factors
Strong balance sheet
Prudent leverage (D/E 0.073) and a strong equity base give XRF durable financial flexibility. Over 2-6 months this supports working capital through cycles, funds targeted investment or acquisitions, and reduces refinancing risk, enabling stable operations and strategic optionality.
Negative Factors
Weakening revenue trend
A recent negative revenue growth rate signals slowing end-market demand or market-share pressure. Persisting revenue contraction risks eroding scale benefits, pressures margins and limits ability to fund sales expansion or R&D, requiring clear recovery initiatives to restore growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet
Prudent leverage (D/E 0.073) and a strong equity base give XRF durable financial flexibility. Over 2-6 months this supports working capital through cycles, funds targeted investment or acquisitions, and reduces refinancing risk, enabling stable operations and strategic optionality.
Read all positive factors
XRF Scientific Limited (XRF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$251.75M
Dividend Yield2.31%
Average Volume (3M)240.16K
Price to Earnings (P/E)13.9
Beta (1Y)1.02
Revenue Growth3.02%
EPS Growth11.08%
CountryAU
Employees48
SectorBasic Materials
Sector Strength58
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)0.08
Shares Outstanding143,040,080
10 Day Avg. Volume163,831
30 Day Avg. Volume240,164
Financial Highlights & Ratios
PEG Ratio1.67
Price to Book (P/B)4.29
Price to Sales (P/S)4.34
P/FCF Ratio30.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.08
Revenue Forecast (FY)AU$64.75M
XRF Scientific Limited Business Overview & Revenue Model
Company Description
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. It operates through Capi...
How the Company Makes Money
XRF makes money primarily by selling and distributing laboratory consumables and equipment used in sample preparation and materials analysis, with recurring revenue generated from repeat purchasing of consumables and replacement parts. Key revenue...
XRF Scientific Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.91M | 59.45M | 59.84M | 55.17M | 40.01M | 31.29M |
| Gross Profit | 30.13M | 28.79M | 26.27M | 22.00M | 16.46M | 12.89M |
| EBITDA | 16.78M | 15.63M | 15.32M | 13.22M | 9.44M | 8.05M |
| Net Income | 10.63M | 10.38M | 8.89M | 7.69M | 6.08M | 5.13M |
Balance Sheet | ||||||
| Total Assets | 70.03M | 72.79M | 68.23M | 65.55M | 55.56M | 48.37M |
| Cash, Cash Equivalents and Short-Term Investments | 12.07M | 12.23M | 12.05M | 10.40M | 6.65M | 5.26M |
| Total Debt | 3.23M | 4.41M | 3.38M | 4.31M | 3.51M | 1.44M |
| Total Liabilities | 8.67M | 12.62M | 12.69M | 15.97M | 12.21M | 9.27M |
| Stockholders Equity | 61.36M | 60.17M | 54.89M | 49.25M | 43.48M | 39.10M |
Cash Flow | ||||||
| Free Cash Flow | 10.17M | 8.39M | 6.45M | 7.63M | 2.63M | 3.86M |
| Operating Cash Flow | 12.10M | 10.14M | 8.09M | 8.42M | 3.15M | 4.51M |
| Investing Cash Flow | -1.77M | -2.21M | -1.64M | -782.43K | -1.11M | -652.62K |
| Financing Cash Flow | -6.40M | -7.75M | -4.80M | -3.88M | -648.95K | -2.24M |
XRF Scientific Limited Technical Analysis
Positive
1.86
Price Trends
1.78
Positive
1.89
Positive
1.98
Negative
Market Momentum
>-0.01
Positive
60.36
Neutral
45.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRF, the sentiment is Positive. The current price of 1.86 is above the 20-day moving average (MA) of 1.83, above the 50-day MA of 1.78, and below the 200-day MA of 1.98, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 60.36 is Neutral, neither overbought nor oversold. The STOCH value of 45.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:XRF.
XRF Scientific Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | AU$251.75M | 13.92 | 17.50% | 2.31% | 3.02% | 11.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | AU$263.76M | -58.52 | -4.01% | ― | ― | 77.84% | |
54 Neutral | AU$139.22M | 4.74 | 2.67% | ― | 593.88% | 80.32% | |
43 Neutral | AU$82.84M | -10.68 | -9.37% | ― | ― | -119.82% | |
42 Neutral | AU$372.11M | -6.45 | -117.09% | ― | ― | -432.83% | |
42 Neutral | AU$739.00M | -1.53 | -63.71% | ― | ― | -1091.18% |
* Basic Materials Sector Average
AU:XRF
XRF Scientific Limited
1.93
0.38
24.19%
AU:MTM
Mt Monger Resources Ltd.
0.52
0.20
60.00%
AU:DTR
Dateline Resources Limited
0.20
0.14
225.00%
AU:KAU
Kaiser Reef Ltd
0.23
0.05
27.78%
AU:GG8
Labyrinth Resources Limited
0.38
-0.13
-25.49%
AU:PTN
Kin Mining NL
0.06
>-0.01
-5.00%
XRF Scientific Limited Corporate Events
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
Apr 26, 2026
XRF Scientific Limited, a Perth-based manufacturer of analytical equipment and chemicals, supplies its technologies to global mining, construction materials and laboratory clients, with operations spanning Australia, Europe, Canada and India and r...
XRF Scientific Buys Bruker’s Combustion Gas Analysis Line in Expansion Drive
Apr 22, 2026
XRF Scientific has agreed to acquire Bruker AXS SE’s Combustion Gas Analysis business, which produces four CS/OHN analysers using hot extraction, inert gas fusion and combustion by induction heating for rapid elemental analysis. The product ...
XRF Scientific lifts quarterly profit on strong international demand and product momentum
Apr 14, 2026
XRF Scientific reported a strong March 2026 quarter, with revenue rising 13.8% to $15.8 million and profit before tax up 10.7% to $3.7 million, driven primarily by international sales growth in Asia across all divisions. Year-to-date revenue for t...
XRF Scientific Seeks ASX Quotation for New Employee Incentive Shares
Mar 4, 2026
XRF Scientific Limited has applied for quotation on the ASX of 47,712 ordinary fully paid shares, with an issue date of 4 March 2026. The new securities have been issued under the company’s employee incentive scheme, indicating ongoing use o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.